Med-Log ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  13.9% 18.1% 11.8% 14.4% 18.5%  
Credit score (0-100)  17 8 19 14 5  
Credit rating  BB B BB BB B  
Credit limit (kDKK)  -0.0 -0.0 -0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  31.5 -23.1 21.6 110 -120  
EBITDA  3.3 -30.1 7.6 103 -154  
EBIT  -23.7 -41.8 7.6 91.5 -160  
Pre-tax profit (PTP)  -27.9 -41.6 1.0 62.3 -163.2  
Net earnings  -27.9 -41.6 1.0 62.3 -129.0  
Pre-tax profit without non-rec. items  -27.9 -41.6 1.0 62.3 -163  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  38.2 0.0 0.0 6.7 0.0  
Shareholders equity total  -71.5 -113 -112 -49.8 -179  
Interest-bearing liabilities  118 122 131 0.0 0.0  
Balance sheet total (assets)  107 61.5 82.2 53.2 83.8  

Net Debt  51.1 60.0 81.3 -33.2 -34.5  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  31.5 -23.1 21.6 110 -120  
Gross profit growth  0.0% 0.0% 0.0% 409.4% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  -100.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  107 62 82 53 84  
Balance sheet change%  -19.3% -42.4% 33.6% -35.3% 57.5%  
Added value  3.3 -30.1 7.6 91.5 -153.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -54 -50 0 -5 -13  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -3.0 -4.0 1.0 2.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -75.1% 180.8% 35.3% 83.3% 133.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -13.4% -23.4% 4.1% 78.9% -87.7%  
ROI %  -29.4% -34.6% 6.0% 100.4% 0.0%  
ROE %  -23.3% -49.5% 1.4% 92.0% -188.4%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -40.1% -64.8% -57.7% -48.4% -68.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  1,552.8% -199.8% 1,068.2% -32.3% 22.4%  
Gearing %  -164.7% -107.5% -116.8% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  5.3% 0.2% 5.2% 5.3% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.4 0.4 0.4 0.5 0.3  
Current Ratio  0.4 0.4 0.4 0.5 0.3  
Cash and cash equivalent  66.6 61.5 49.7 33.2 34.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -109.7 -113.1 -112.1 -56.5 -178.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0